24-hour Efficacy of AR-12286
Completed · Phase 2
Conditions studied: Open Angle Glaucoma, Ocular Hypertension
In brief
An open-label, non-comparative, pilot evaluation of the 24-hour ocular hypotensive efficacy of AR-12286 in patients with open-angle glaucoma or ocular hypertension
Key facts
- Study ID
- NCT01330979
- Run by
- Aerie Pharmaceuticals
- People needed
- 5
- Starts
- 2011-05-01
- Expected to finish
- 2012-08-01
- Last updated by the study team
- 2014-04-21
Who can join
Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California — San Diego, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.